BRCB Black Rock reports 81 percent Q4 2025 EPS upside shares drop 427 percent amid unclear revenue outlook Regeneron Pharmaceuticals REGN Secures Dupixent Pediatric EU Approval Enters Radiopharmaceuticals Via Telix Collaboration Western SBI Stock Growth Outlook Institutional Demand 20260420 Peoples PFIS Stock Sector Opportunities 080 20260423